The Lumir Mission Medicinal Cannabis for Primary Dysmenorrhoea Study

Dysmenorrhoea is the leading cause of pelvic pain in women, affecting 45-95 per cent of menstruating women. Primary Dysmenorrhoea is period pain without a structural cause (Secondary Dysmenorrhea being associated with medical conditions such as endometriosis, and outside of the scope of this study).

Primary Dysmenorrhoea is common, debilitating, and currently management is focused on pain relief and non-steroidal anti-inflammatory drugs, acetaminophen (paracetamol) and/or hormonal contraception which many women don’t respond to, and many of the existing pain-relief medications have side effects.

Characterised by cramping pain in the lower abdomen before or during the menstrual period in the absence of any pelvic pathology (such as endometriosis), symptoms include nausea, vomiting, diarrhoea, fatigue, headache and light headedness, and medical cannabis may be one solution for managing these symptoms.

The study aims to assess the potential effectiveness of medical cannabis in alleviating period pain over a 6-month duration.

You can read more on the NICM Health Research Institute website where suitable candidates can enrol now, or call the study team on 1300 413 379 for more information.